Skip to main content

Table 5 EQ-5D index scores following first 8% capsaicin patch treatment

From: Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study

EQ-5D index score

Responders at Weeks 2 and 8

Non-responders at Weeks 2 and 8

Overall

 

≥30%a

≥50%a

<30%a

<50%a

 

Baseline, mean (SD)

0.392 (0.352)

n = 182

0.386 (0.367)

n = 108

0.306 (0.349)

n = 229

0.329 (0.347)

n = 303

0.345 (0.354)

n = 419

Change from baseline, mean (SD)

 Week 2

0.292 (0.313)

n = 176

0.337 (0.327)

n = 104

0.128 (0.297)

n = 223

0.152 (0.296)

n = 295

0.199 (0.315)

n = 400

 Week 8

0.323 (0.307)

n = 165

0.349 (0.321)

n = 99

0.104 (0.323)

n = 209

0.147 (0.322)

n = 275

0.200 (0.333)

n = 375

 Week 12

0.289 (0.352)

n = 165

0.342 (0.359)

n = 97

0.111 (0.320)

n = 196

0.138 (0.325)

n = 264

0.190 (0.348)

n = 363

 Week 26

0.288 (0.292)

n = 93

0.309 (0.290)

n = 62

0.099 (0.339)

n = 112

0.131 (0.334)

n = 143

0.185 (0.330)

n = 206

 Week 39

0.306 (0.320)

n = 78

0.310 (0.321)

n = 52

0.123 (0.335)

n = 96

0.161 (0.339)

n = 122

0.205 (0.340)

n = 174

 Week 52

0.307 (0.327)

n = 76

0.305 (0.330)

n = 52

0.114 (0.376)

n = 100

0.153 (0.373)

n = 124

0.198 (0.367)

n = 176

  1. aPercentage reduction in average NPRS score. EQ-5D, EuroQol 5 Dimension 3-level; SD, standard deviation